Choosing the Right Grant Type

How to Apply for a FARA Research Grant

FARA accepts letters of intent for projects that fall within FARA’s research priorities as General Research Grants twice a year.  In addition to the General Research Grant, FARA funds grants either targeted to focused areas of research or aimed at nurturing young investigators.

The Keith Michael Andrus Cardiac Award, the Bronya J. Keats Collaboration Award, and the Kyle Bryant Translational Research Award accept applications once a year respectively on the cardiomyopathy in FA, collaboration between investigators, and on translational research projects. These grants are awarded for 1-2 years in duration. FARA also offers Postdoctoral Research Awards as well as Postdoctoral and Graduate Research Fellowships to expand and retain young investigators in the FA biomedical research space. Finally, FARA funds the Award for Innovative Mindset, a one-year grant for the initial exploration of innovative, high-risk, high-gain, and potentially groundbreaking concepts in FA research.  This award does not require a letter of intent.  You can review the aims, budgets, and submission timelines of each grant type by clicking the button below to determine the best fit for your grant proposal.

Grant application process infographic

1. Letter of Intent (LOI)

All LOIs must be submitted using FARA’s grant submission portal. The LOI must explain how the proposed research addresses FARA’s grant program priorities. This is a competitive, peer-review process, as such only a small number of applications are accepted past the LOI phase.

Junior investigators and postdoctoral trainees who would like support through the application process or general advice on grant writing may contact FARA at grants@curefa.org.

A Letter of Intent (LOI) is required for all grant applications (except the Award for Innovative Mindset) and must include two PDF files:

The first PDF should describe:

  • The rationale for the proposed project and how the research fits within FARA’s grant program priorities (up to 1 page).
  • The hypothesis to be tested and the specific aims (up to 1 page).
  • Key preliminary data of direct relevance to FA (no more than 2 pages).
  • References
  • Estimate of budget request with justification. The budget limit for each grant type must be met. However, for General Research Grant applications, budgets exceeding $125,000/year will be considered if adequately justified (e.g., in a case of collaborations involving multiple PIs). The maximum direct salary that can be requested cannot exceed the NIH salary cap. Please note the grant funding start dates for each cycle. Click here and select your submission cycle accordingly.

The second PDF should provide the CV/biosketch for Principal Investigator (including contact information) and all other key personnel.

For Graduate Research Fellowships, Postdoctoral Fellowships and Postdoctoral Research Awards, this PDF file must also include a 1-2 page personal statement of career goals and how the proposed research and research training environment will facilitate achieving these goals. In addition, a mentorship plan developed jointly by the postdoctoral scholar and mentor(s) must be included, as well as letters of support from mentor(s).

2. Application

All applications must be submitted using FARA’s grant submission portal. This includes a lay summary of the project, budget and a timeline with detailed milestones. The project description, curriculum vitae/biosketch of each of the key investigators, letters of support, and other relevant documents must be submitted as PDF files.

Click here for special application requirements for the Award for Innovative Mindset.

Project Description
The description of the project (excluding references to literature) should not exceed 10 pages, which includes the specific aims, background, preliminary data, and research plan, plus a brief statement on the suitability of the scientific environment and the availability of the necessary resources/equipment for the proposed research. This page limit excludes references and applies to grants less than $150,000. Larger grants do not have page number restrictions. All grant proposals must provide adequate detail for reviewer evaluation.

Budget
A detailed budget must be submitted with all proposals, including a justification of all requested expenses. Allowable expenses are: personnel costs/salary with fringe benefits, laboratory reagents and supplies, equipment, animal expenses, publication costs, investigator travel to meetings and conferences and to facilitate collaborations, patient expenses directly related to study and not reimbursable by third party insurers, and patient travel. Expenses that will not be awarded include: indirect costs/overhead, supplementing a postdoc fellowship/research award stipend with another FARA grant, memberships in scientific societies. Budget justification for investigator travel to meetings, conferences and to facilitate collaborations must include the destination, number of people traveling and dates or duration of stay for all anticipated travel, and clearly state how the travel is directly related to the proposed research. Budget limits for each grant type must be met. However, for General Research Grant applications, budgets exceeding 125,000/year will be considered if adequately justified, for example in the case of collaborations involving multiple PIs. The maximum direct salary that can be requested cannot exceed the NIH salary cap.

For Graduate Research Fellowships, the only allowable budget items are the graduate student’s salary/stipend plus applicable fringe benefits (including health insurance) and tuition costs and fees that are not already covered by the institution.

Milestones
All projects must have objective milestones that are clearly communicated. We appreciate that some projects, especially those that are more basic-science-oriented, might need to have milestone adjustments based on specific experimental outcomes. If the proposal is funded, FARA will utilize the proposed milestones for scheduling progress reports and monitoring the project.

Human Subjects
If human subjects are used in the proposed study, the study must be approved by the Institutional Review Board (IRB) or equivalent. Full funding will not be provided until proof of IRB approval is demonstrated to FARA. Human subjects studied during research conducted under a FARA grant are under no circumstances a responsibility of FARA.

Animal Research
If animals are used, the proposed study must be approved by the Institutional Animal Care and Use Committee (IACUC), or equivalent, indicating that appropriate precautions have been taken to assure that proper treatment, care, and humane conditions are provided.

Other Documents
This can include all supporting materials such as appendices, institutional transmittal forms, letters of support, etc.

3. Review and Decision Process

All grant applications submitted to FARA undergo a rigorous and confidential review procedure that is overseen by the FARA Scientific Review Committee (SRC).

  1. The SRC makes a preliminary review and if the application is considered acceptable, it undergoes external peer-review by established researchers with the appropriate expertise. The reviewers are assigned by the SRC, often based on suggestions provided by the applicant. All reviewers confirm that they do not have a conflict of interest before reviewing a grant application. Click here to read FARA’s guidelines on assessing conflict of interest.
  2. Each reviewer provides a score for the “Overall Impact” of the proposal, as well as scores for 5 specific criteria (significance, investigator, innovation, approach/methods, and environment/resources), and comments that justify the scores given for these criteria.
  3. Sometimes reviewers raise questions to the applicants, questions that are critical to determine whether a proposal should be recommended for funding:
    a) When these questions can be addressed quickly, the applicant is asked to provide a response to the reviewer comments, usually within a month. If the SRC finds the applicant’s response to the reviewer comments satisfactory, the application will be moved forward.
    b) If a more detailed response is required, the applicant will be asked to submit a response to the reviewer comments and a revised application by the next grant cycle deadline. This rebuttal will be sent back to the original reviewers or to additional reviewers for their comments. These revised applications will compete for funding with all applications received in the following grant cycle.
  4. Following this thorough discussion of the reviews, as well as the significance and relevance of the proposed research to FARA’s mission and strategic research priorities, the SRC submits those applications for which funding is recommended to the FARA Board of Directors (Executive Committee).
  5. In making a final funding decision, the FARA Executive Committee considers the reviewer comments, the SRC comments and recommendation, the importance and priority level of the proposed research to FARA’s goals, and the availability of funds in the FARA treasury (including an assessment of future commitments and requirements).
  6. Only applications that are recommended for funding by the SRC will be considered for funding by the FARA Executive Committee. The funding decision made by the FARA Executive Committee is final.

4. Reporting Requirements

All FARA grantees must submit annual scientific and financial reports using FARA’s grant submission portal. For Graduate Research Fellowships, a yearly statement of continuing support by the mentor is also required. The required frequency of reports will be stated in the formal funding agreement with FARA. Each report must be submitted to the portal as a PDF file.

Continuation funding will not be provided until all required progress reports are received and reviewed by the FARA SRC, and approved for funding by the FARA Executive Committee.

Any rebudgeting of funds requires prior FARA approval. Please submit rebudgeting requests by email at grants@curefa.org indicating the amount to be rebudgeted, spending categories involved and an explanation of why the rebudgeting is needed.

FARA also encourages investigators to present their FARA-funded research at least once during the course of their grant at the FARA Forum, on a mutually agreed upon date. The Forum is a monthly webinar open to FARA grant awardees and the FARA Scientific Advisory Board and it is held on the second Tuesday of every month.

 

Instructions and Format for Progress and Final Project Reports

Interim progress reports are due by the end of the annual project period (unless more frequent reports are requested). The Final report is due no later than one month after the end of the grant.  The reports must include the following sections:

  • Lay summary of progress towards achieving goals and research plans for the next year, including significance of work to development of therapies for FA (maximum of 500 words).
  • Executive summary that outlines in bulleted-format all proposed goals achieved and a results overview.
  • Assessment of milestone achievement the year of work completed and – for grants awarded two years of funding – for the year of work to come.
  • Scientific report of research results and progress against milestones and research objectives for upcoming term of grant (maximum of four pages).
  • List of publications and presentations that have resulted from FARA funding for this project (Provide a PDF of each publication).
  • Patents received/pending and products developed because of FARA funding for this project.
  • Other grants received by the FARA grantee for FA research projects over the past year (agency, title, funding period, overlap with this FARA project).
  • Budget status
    • Financial report documenting allocation/use of funds expended from grant during term of award.
      As stipulated in the contractual agreement with FARA, an official financial statement from the recipient institution must be received no later than three months after the end of the grant year.
    • Amount and justification of request for the next project period, if applicable.
    • At the end of the funding period, unspent funds must be returned to FARA unless a request for carryover to the next grant period or a request for a no-cost extension is submitted to FARA.

Request for a No-cost Extension and/or Carryover of Funds

A request for a no-cost extension of up to one year will be considered if the reason for the request is compelling. This request needs to be submitted as part of the progress report. The investigator must explain why the funds were not spent, why the extension is needed, and how the carry-over funds will be used to advance the research project.

For a 2-year grant, FARA will consider a request for carry-over funds at the end of the first year. The request must be submitted as part of the first year progress report, and a detailed explanation must be provided.

If circumstances arise during the funding period that interfere with the progress of the funded research and make it likely that a request will be made for a no-cost extension and/or carry-over of funds, the investigator is strongly advised to inform FARA immediately.

5. General Policies

LOIs and invited grant applications must meet the specified deadlines. Exceptions are made only for projects of high priority to FARA. With compelling justification for special consideration, investigators with high-priority projects may submit LOIs throughout the year and may also have a budget greater than $125,000 per year. Please submit all special consideration requests and LOIs via email, grants@curefa.org.

Occasionally FARA may issue Requests For Proposals (RFPs) targeting a high priority research area. Each RFP will have its own specific deadline and budget limit.

FARA funds only direct costs. Indirect costs will not be awarded.

Grant awards are made in one-year allocations. As stipulated in the contractual agreement with FARA, satisfactory progress reports (following the instructions under Reporting Requirements) must be received before FARA will provide funds for the second year of a 2-year project.

All unused funds at the end of each year must be returned to FARA unless a request for carryover to the next grant period or a request for a no-cost extension is submitted to FARA FARA reserves the right to terminate any grant award for inadequate progress, failure to submit reports, deviation in scope of the original research, and/or changes in FARA funding priorities. If an award is terminated, all unused funds must be returned to FARA.

6. General Guidelines for Junior Investigators

Growing and developing the FA research community is a priority for FARA. As such, FARA encourages applications from junior investigators and young clinicians. Reviewers consider the investigator’s career stage and will review the grant application with this information in mind. For Graduate Research Fellowships, Postdoctoral Fellowships and Postdoctoral Research Awards FARA requires junior investigators to submit a personal statement describing their current position and plans for the future as it relates to FA research, with a description of career goals and how the proposed research and research environment will favor achieving those goals. A mentoring plan developed jointly by the junior investigator and mentor(s), as well as letters of support from all mentors are also required. If junior investigators would like support through the application process or general advice on grant writing, they may contact grants@curefa.org.

7. General Guidelines for Industry

FARA will accept grant submissions from industry partners who have a demonstrated participation in the FA research community and are advancing therapeutic candidates for FA. FARA requires that a letter of intent (LOI) be submitted prior to the submission of a grant proposal. All projects/requests should be:

  • Directly related to advancing a therapeutic candidate closer to clinic, and/or
  • Addressing an FA-specific issue that could be of benefit to the entire field, such as biomarker validation or mechanism of action.

FARA will also accept proposals for direct patient-related expenses for clinical studies.

Letter of Intent and Applications

  • LOIs and Applications must contain enough preliminary data and be detailed enough to allow reviewers to assess the significance and feasibility of the proposed work and indicate if Intellectual Property related to the proposal exists. Please refer to the sections above on the LOIs and Applications for specific instructions.
  • The LOI must include rationale/justification for applying to FARA for funding.
    • Please address how funding from FARA is essential to program development. For example, will the funding enable addition of FA to the company pipeline, attract other funders, or provide proof of concept of the company technology to address a gap in the FA research pipeline?
  • Priority will be given to companies when the grant will generate data to move forward with FA as indication.
  • Priority will be given to companies when proposed studies will help fill a gap in the FA pipeline.

Grant Review Process

In addition to scientific review, a grant application from a for-profit entity will also be reviewed for its commercial viability by FARA board members.

Award for Innovative Mindset

AIM grants do not require an LOI. Please submit your AIM proposal using the LOI submission form in FARA’s grant submission portal. For more information about the Award for Innovative Mindset, click here.

Submission
Please submit your proposal here, by using the LOI submission form and uploading all required information. Please select “Award for Innovative Mindset” from the dropdown menu when submitting the application.

Requirements
The proposal has a four-page limit that applies to text and non-text elements (e.g., figures, tables, graphs, photographs, diagrams, chemical structures, drawings) used to describe the project. References are not included in the page limit. The presentation of preliminary and/or published data is encouraged, but not required.  Describe the proposed project in detail using the outline below.

  • Rationale: Clearly articulate the rationale for the proposed research project. The presentation of preliminary and/or published data is encouraged, but not required.
  • Innovation: Provide a brief summary of the proposed research that emphasizes the innovation it brings to the field of FA and the potential impact of this line of investigation.
  • Hypothesis: State concisely the specific hypothesis that will be tested as it relates to a new concept, theory, paradigm, and/or method that addresses an important problem in FA research.
  • Specific Aims: Concisely explain the proposed research project’s specific aims.
  • Research Strategy and Feasibility: Describe the experimental design, methods, and analyses, including appropriate controls, in sufficient detail for scientific peer review. Address potential problem areas and present alternative methods and approaches. State clearly how you are qualified to test the specific hypothesis you are putting forward.

The proposal should also include a brief lay summary and an estimate of the budget with justification (not included in the four-page limit), as well as the CVs/biosketches for the Principal Investigator (PI) and co-investigators (if any are included). The anticipated direct costs budgeted must not exceed $100,000. FARA does not fund indirect costs.
Investigators at all academic levels (or equivalent) may be named as the PI on the application. We particularly encourage junior investigators to apply.

Only highly competitive proposals that are considered feasible will be peer-reviewed; no feedback will be provided for applications that are not reviewed. The award recipients will be announced by May 1 and the grant start date will be between June 1 and July 1.

Review Process
All applications are first reviewed by the members of the FARA Scientific Review Committee (SRC), who score each application for innovation and impact. Those that rank highly then undergo full external peer-review. The external reviewers are selected by the SRC and each of the reviewers provides comments and scores for innovation, impact and approach.